Global Tumor NGS Detection Supply, Demand and Key Producers, 2023-2029
The global Tumor NGS Detection market size is expected to reach $ 5059.4 million by 2029, rising at a market growth of 15.1% CAGR during the forecast period (2023-2029).
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
This report studies the global Tumor NGS Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor NGS Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor NGS Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor NGS Detection total market, 2018-2029, (USD Million)
Global Tumor NGS Detection total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor NGS Detection total market, key domestic companies and share, (USD Million)
Global Tumor NGS Detection revenue by player and market share 2018-2023, (USD Million)
Global Tumor NGS Detection total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor NGS Detection total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Tumor NGS Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine, Sinopharm Group, Fosunpharma, Novogene, Geneseeq and AmoyDx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor NGS Detection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor NGS Detection Market, By Region:
1. How big is the global Tumor NGS Detection market?
2. What is the demand of the global Tumor NGS Detection market?
3. What is the year over year growth of the global Tumor NGS Detection market?
4. What is the total value of the global Tumor NGS Detection market?
5. Who are the major players in the global Tumor NGS Detection market?
6. What are the growth factors driving the market demand?
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
This report studies the global Tumor NGS Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor NGS Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor NGS Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor NGS Detection total market, 2018-2029, (USD Million)
Global Tumor NGS Detection total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor NGS Detection total market, key domestic companies and share, (USD Million)
Global Tumor NGS Detection revenue by player and market share 2018-2023, (USD Million)
Global Tumor NGS Detection total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor NGS Detection total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Tumor NGS Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine, Sinopharm Group, Fosunpharma, Novogene, Geneseeq and AmoyDx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor NGS Detection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor NGS Detection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Medical Equipment
- Consumables
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Other
- Agilent
- Thermo Fisher Scientific
- BGI Group
- Roche Foundation Medicine
- Sinopharm Group
- Fosunpharma
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- Perkin Elmer
- Qiagen NV
- Partek
- Illumina Inc.
- Pacific Biosciences of California Inc.
- Life Technologies Corporation
- GTH.O
- Paradigm Diagnostics
- Oxford Nanopore Technologies Ltd.
- Eurofins Scientific S.E.
1. How big is the global Tumor NGS Detection market?
2. What is the demand of the global Tumor NGS Detection market?
3. What is the year over year growth of the global Tumor NGS Detection market?
4. What is the total value of the global Tumor NGS Detection market?
5. Who are the major players in the global Tumor NGS Detection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tumor NGS Detection Introduction
1.2 World Tumor NGS Detection Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Tumor NGS Detection Total Market by Region (by Headquarter Location)
1.3.1 World Tumor NGS Detection Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Tumor NGS Detection Market Size (2018-2029)
1.3.3 China Tumor NGS Detection Market Size (2018-2029)
1.3.4 Europe Tumor NGS Detection Market Size (2018-2029)
1.3.5 Japan Tumor NGS Detection Market Size (2018-2029)
1.3.6 South Korea Tumor NGS Detection Market Size (2018-2029)
1.3.7 ASEAN Tumor NGS Detection Market Size (2018-2029)
1.3.8 India Tumor NGS Detection Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor NGS Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor NGS Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor NGS Detection Consumption Value (2018-2029)
2.2 World Tumor NGS Detection Consumption Value by Region
2.2.1 World Tumor NGS Detection Consumption Value by Region (2018-2023)
2.2.2 World Tumor NGS Detection Consumption Value Forecast by Region (2024-2029)
2.3 United States Tumor NGS Detection Consumption Value (2018-2029)
2.4 China Tumor NGS Detection Consumption Value (2018-2029)
2.5 Europe Tumor NGS Detection Consumption Value (2018-2029)
2.6 Japan Tumor NGS Detection Consumption Value (2018-2029)
2.7 South Korea Tumor NGS Detection Consumption Value (2018-2029)
2.8 ASEAN Tumor NGS Detection Consumption Value (2018-2029)
2.9 India Tumor NGS Detection Consumption Value (2018-2029)
3 WORLD TUMOR NGS DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumor NGS Detection Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor NGS Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor NGS Detection in 2022
3.2.3 Global Concentration Ratios (CR8) for Tumor NGS Detection in 2022
3.3 Tumor NGS Detection Company Evaluation Quadrant
3.4 Tumor NGS Detection Market: Overall Company Footprint Analysis
3.4.1 Tumor NGS Detection Market: Region Footprint
3.4.2 Tumor NGS Detection Market: Company Product Type Footprint
3.4.3 Tumor NGS Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumor NGS Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor NGS Detection Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Tumor NGS Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Tumor NGS Detection Consumption Value Comparison
4.2.1 United States VS China: Tumor NGS Detection Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor NGS Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Tumor NGS Detection Companies and Market Share, 2018-2023
4.3.1 United States Based Tumor NGS Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor NGS Detection Revenue, (2018-2023)
4.4 China Based Companies Tumor NGS Detection Revenue and Market Share, 2018-2023
4.4.1 China Based Tumor NGS Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor NGS Detection Revenue, (2018-2023)
4.5 Rest of World Based Tumor NGS Detection Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Tumor NGS Detection Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor NGS Detection Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor NGS Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Medical Equipment
5.2.2 Consumables
5.3 Market Segment by Type
5.3.1 World Tumor NGS Detection Market Size by Type (2018-2023)
5.3.2 World Tumor NGS Detection Market Size by Type (2024-2029)
5.3.3 World Tumor NGS Detection Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor NGS Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Companion Diagnostics
6.2.2 Early Cancer Screening
6.2.3 Drug Discovery
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Tumor NGS Detection Market Size by Application (2018-2023)
6.3.2 World Tumor NGS Detection Market Size by Application (2024-2029)
6.3.3 World Tumor NGS Detection Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Agilent
7.1.1 Agilent Details
7.1.2 Agilent Major Business
7.1.3 Agilent Tumor NGS Detection Product and Services
7.1.4 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Recent Developments/Updates
7.1.6 Agilent Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific Tumor NGS Detection Product and Services
7.2.4 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 BGI Group
7.3.1 BGI Group Details
7.3.2 BGI Group Major Business
7.3.3 BGI Group Tumor NGS Detection Product and Services
7.3.4 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BGI Group Recent Developments/Updates
7.3.6 BGI Group Competitive Strengths & Weaknesses
7.4 Roche Foundation Medicine
7.4.1 Roche Foundation Medicine Details
7.4.2 Roche Foundation Medicine Major Business
7.4.3 Roche Foundation Medicine Tumor NGS Detection Product and Services
7.4.4 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Foundation Medicine Recent Developments/Updates
7.4.6 Roche Foundation Medicine Competitive Strengths & Weaknesses
7.5 Sinopharm Group
7.5.1 Sinopharm Group Details
7.5.2 Sinopharm Group Major Business
7.5.3 Sinopharm Group Tumor NGS Detection Product and Services
7.5.4 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sinopharm Group Recent Developments/Updates
7.5.6 Sinopharm Group Competitive Strengths & Weaknesses
7.6 Fosunpharma
7.6.1 Fosunpharma Details
7.6.2 Fosunpharma Major Business
7.6.3 Fosunpharma Tumor NGS Detection Product and Services
7.6.4 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Fosunpharma Recent Developments/Updates
7.6.6 Fosunpharma Competitive Strengths & Weaknesses
7.7 Novogene
7.7.1 Novogene Details
7.7.2 Novogene Major Business
7.7.3 Novogene Tumor NGS Detection Product and Services
7.7.4 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novogene Recent Developments/Updates
7.7.6 Novogene Competitive Strengths & Weaknesses
7.8 Geneseeq
7.8.1 Geneseeq Details
7.8.2 Geneseeq Major Business
7.8.3 Geneseeq Tumor NGS Detection Product and Services
7.8.4 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Geneseeq Recent Developments/Updates
7.8.6 Geneseeq Competitive Strengths & Weaknesses
7.9 AmoyDx
7.9.1 AmoyDx Details
7.9.2 AmoyDx Major Business
7.9.3 AmoyDx Tumor NGS Detection Product and Services
7.9.4 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 AmoyDx Recent Developments/Updates
7.9.6 AmoyDx Competitive Strengths & Weaknesses
7.10 Burning Rock Medicine
7.10.1 Burning Rock Medicine Details
7.10.2 Burning Rock Medicine Major Business
7.10.3 Burning Rock Medicine Tumor NGS Detection Product and Services
7.10.4 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Burning Rock Medicine Recent Developments/Updates
7.10.6 Burning Rock Medicine Competitive Strengths & Weaknesses
7.11 Perkin Elmer
7.11.1 Perkin Elmer Details
7.11.2 Perkin Elmer Major Business
7.11.3 Perkin Elmer Tumor NGS Detection Product and Services
7.11.4 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Perkin Elmer Recent Developments/Updates
7.11.6 Perkin Elmer Competitive Strengths & Weaknesses
7.12 Qiagen NV
7.12.1 Qiagen NV Details
7.12.2 Qiagen NV Major Business
7.12.3 Qiagen NV Tumor NGS Detection Product and Services
7.12.4 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Qiagen NV Recent Developments/Updates
7.12.6 Qiagen NV Competitive Strengths & Weaknesses
7.13 Partek
7.13.1 Partek Details
7.13.2 Partek Major Business
7.13.3 Partek Tumor NGS Detection Product and Services
7.13.4 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Partek Recent Developments/Updates
7.13.6 Partek Competitive Strengths & Weaknesses
7.14 Illumina Inc.
7.14.1 Illumina Inc. Details
7.14.2 Illumina Inc. Major Business
7.14.3 Illumina Inc. Tumor NGS Detection Product and Services
7.14.4 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Illumina Inc. Recent Developments/Updates
7.14.6 Illumina Inc. Competitive Strengths & Weaknesses
7.15 Pacific Biosciences of California Inc.
7.15.1 Pacific Biosciences of California Inc. Details
7.15.2 Pacific Biosciences of California Inc. Major Business
7.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Product and Services
7.15.4 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Pacific Biosciences of California Inc. Recent Developments/Updates
7.15.6 Pacific Biosciences of California Inc. Competitive Strengths & Weaknesses
7.16 Life Technologies Corporation
7.16.1 Life Technologies Corporation Details
7.16.2 Life Technologies Corporation Major Business
7.16.3 Life Technologies Corporation Tumor NGS Detection Product and Services
7.16.4 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Life Technologies Corporation Recent Developments/Updates
7.16.6 Life Technologies Corporation Competitive Strengths & Weaknesses
7.17 GTH.O
7.17.1 GTH.O Details
7.17.2 GTH.O Major Business
7.17.3 GTH.O Tumor NGS Detection Product and Services
7.17.4 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 GTH.O Recent Developments/Updates
7.17.6 GTH.O Competitive Strengths & Weaknesses
7.18 Paradigm Diagnostics
7.18.1 Paradigm Diagnostics Details
7.18.2 Paradigm Diagnostics Major Business
7.18.3 Paradigm Diagnostics Tumor NGS Detection Product and Services
7.18.4 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Paradigm Diagnostics Recent Developments/Updates
7.18.6 Paradigm Diagnostics Competitive Strengths & Weaknesses
7.19 Oxford Nanopore Technologies Ltd.
7.19.1 Oxford Nanopore Technologies Ltd. Details
7.19.2 Oxford Nanopore Technologies Ltd. Major Business
7.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product and Services
7.19.4 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Oxford Nanopore Technologies Ltd. Recent Developments/Updates
7.19.6 Oxford Nanopore Technologies Ltd. Competitive Strengths & Weaknesses
7.20 Eurofins Scientific S.E.
7.20.1 Eurofins Scientific S.E. Details
7.20.2 Eurofins Scientific S.E. Major Business
7.20.3 Eurofins Scientific S.E. Tumor NGS Detection Product and Services
7.20.4 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Eurofins Scientific S.E. Recent Developments/Updates
7.20.6 Eurofins Scientific S.E. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor NGS Detection Industry Chain
8.2 Tumor NGS Detection Upstream Analysis
8.3 Tumor NGS Detection Midstream Analysis
8.4 Tumor NGS Detection Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Tumor NGS Detection Introduction
1.2 World Tumor NGS Detection Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Tumor NGS Detection Total Market by Region (by Headquarter Location)
1.3.1 World Tumor NGS Detection Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Tumor NGS Detection Market Size (2018-2029)
1.3.3 China Tumor NGS Detection Market Size (2018-2029)
1.3.4 Europe Tumor NGS Detection Market Size (2018-2029)
1.3.5 Japan Tumor NGS Detection Market Size (2018-2029)
1.3.6 South Korea Tumor NGS Detection Market Size (2018-2029)
1.3.7 ASEAN Tumor NGS Detection Market Size (2018-2029)
1.3.8 India Tumor NGS Detection Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor NGS Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor NGS Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor NGS Detection Consumption Value (2018-2029)
2.2 World Tumor NGS Detection Consumption Value by Region
2.2.1 World Tumor NGS Detection Consumption Value by Region (2018-2023)
2.2.2 World Tumor NGS Detection Consumption Value Forecast by Region (2024-2029)
2.3 United States Tumor NGS Detection Consumption Value (2018-2029)
2.4 China Tumor NGS Detection Consumption Value (2018-2029)
2.5 Europe Tumor NGS Detection Consumption Value (2018-2029)
2.6 Japan Tumor NGS Detection Consumption Value (2018-2029)
2.7 South Korea Tumor NGS Detection Consumption Value (2018-2029)
2.8 ASEAN Tumor NGS Detection Consumption Value (2018-2029)
2.9 India Tumor NGS Detection Consumption Value (2018-2029)
3 WORLD TUMOR NGS DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumor NGS Detection Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor NGS Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor NGS Detection in 2022
3.2.3 Global Concentration Ratios (CR8) for Tumor NGS Detection in 2022
3.3 Tumor NGS Detection Company Evaluation Quadrant
3.4 Tumor NGS Detection Market: Overall Company Footprint Analysis
3.4.1 Tumor NGS Detection Market: Region Footprint
3.4.2 Tumor NGS Detection Market: Company Product Type Footprint
3.4.3 Tumor NGS Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumor NGS Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor NGS Detection Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Tumor NGS Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Tumor NGS Detection Consumption Value Comparison
4.2.1 United States VS China: Tumor NGS Detection Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor NGS Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Tumor NGS Detection Companies and Market Share, 2018-2023
4.3.1 United States Based Tumor NGS Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor NGS Detection Revenue, (2018-2023)
4.4 China Based Companies Tumor NGS Detection Revenue and Market Share, 2018-2023
4.4.1 China Based Tumor NGS Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor NGS Detection Revenue, (2018-2023)
4.5 Rest of World Based Tumor NGS Detection Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Tumor NGS Detection Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor NGS Detection Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor NGS Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Medical Equipment
5.2.2 Consumables
5.3 Market Segment by Type
5.3.1 World Tumor NGS Detection Market Size by Type (2018-2023)
5.3.2 World Tumor NGS Detection Market Size by Type (2024-2029)
5.3.3 World Tumor NGS Detection Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor NGS Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Companion Diagnostics
6.2.2 Early Cancer Screening
6.2.3 Drug Discovery
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Tumor NGS Detection Market Size by Application (2018-2023)
6.3.2 World Tumor NGS Detection Market Size by Application (2024-2029)
6.3.3 World Tumor NGS Detection Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Agilent
7.1.1 Agilent Details
7.1.2 Agilent Major Business
7.1.3 Agilent Tumor NGS Detection Product and Services
7.1.4 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Recent Developments/Updates
7.1.6 Agilent Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific Tumor NGS Detection Product and Services
7.2.4 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 BGI Group
7.3.1 BGI Group Details
7.3.2 BGI Group Major Business
7.3.3 BGI Group Tumor NGS Detection Product and Services
7.3.4 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BGI Group Recent Developments/Updates
7.3.6 BGI Group Competitive Strengths & Weaknesses
7.4 Roche Foundation Medicine
7.4.1 Roche Foundation Medicine Details
7.4.2 Roche Foundation Medicine Major Business
7.4.3 Roche Foundation Medicine Tumor NGS Detection Product and Services
7.4.4 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Foundation Medicine Recent Developments/Updates
7.4.6 Roche Foundation Medicine Competitive Strengths & Weaknesses
7.5 Sinopharm Group
7.5.1 Sinopharm Group Details
7.5.2 Sinopharm Group Major Business
7.5.3 Sinopharm Group Tumor NGS Detection Product and Services
7.5.4 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sinopharm Group Recent Developments/Updates
7.5.6 Sinopharm Group Competitive Strengths & Weaknesses
7.6 Fosunpharma
7.6.1 Fosunpharma Details
7.6.2 Fosunpharma Major Business
7.6.3 Fosunpharma Tumor NGS Detection Product and Services
7.6.4 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Fosunpharma Recent Developments/Updates
7.6.6 Fosunpharma Competitive Strengths & Weaknesses
7.7 Novogene
7.7.1 Novogene Details
7.7.2 Novogene Major Business
7.7.3 Novogene Tumor NGS Detection Product and Services
7.7.4 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novogene Recent Developments/Updates
7.7.6 Novogene Competitive Strengths & Weaknesses
7.8 Geneseeq
7.8.1 Geneseeq Details
7.8.2 Geneseeq Major Business
7.8.3 Geneseeq Tumor NGS Detection Product and Services
7.8.4 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Geneseeq Recent Developments/Updates
7.8.6 Geneseeq Competitive Strengths & Weaknesses
7.9 AmoyDx
7.9.1 AmoyDx Details
7.9.2 AmoyDx Major Business
7.9.3 AmoyDx Tumor NGS Detection Product and Services
7.9.4 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 AmoyDx Recent Developments/Updates
7.9.6 AmoyDx Competitive Strengths & Weaknesses
7.10 Burning Rock Medicine
7.10.1 Burning Rock Medicine Details
7.10.2 Burning Rock Medicine Major Business
7.10.3 Burning Rock Medicine Tumor NGS Detection Product and Services
7.10.4 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Burning Rock Medicine Recent Developments/Updates
7.10.6 Burning Rock Medicine Competitive Strengths & Weaknesses
7.11 Perkin Elmer
7.11.1 Perkin Elmer Details
7.11.2 Perkin Elmer Major Business
7.11.3 Perkin Elmer Tumor NGS Detection Product and Services
7.11.4 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Perkin Elmer Recent Developments/Updates
7.11.6 Perkin Elmer Competitive Strengths & Weaknesses
7.12 Qiagen NV
7.12.1 Qiagen NV Details
7.12.2 Qiagen NV Major Business
7.12.3 Qiagen NV Tumor NGS Detection Product and Services
7.12.4 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Qiagen NV Recent Developments/Updates
7.12.6 Qiagen NV Competitive Strengths & Weaknesses
7.13 Partek
7.13.1 Partek Details
7.13.2 Partek Major Business
7.13.3 Partek Tumor NGS Detection Product and Services
7.13.4 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Partek Recent Developments/Updates
7.13.6 Partek Competitive Strengths & Weaknesses
7.14 Illumina Inc.
7.14.1 Illumina Inc. Details
7.14.2 Illumina Inc. Major Business
7.14.3 Illumina Inc. Tumor NGS Detection Product and Services
7.14.4 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Illumina Inc. Recent Developments/Updates
7.14.6 Illumina Inc. Competitive Strengths & Weaknesses
7.15 Pacific Biosciences of California Inc.
7.15.1 Pacific Biosciences of California Inc. Details
7.15.2 Pacific Biosciences of California Inc. Major Business
7.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Product and Services
7.15.4 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Pacific Biosciences of California Inc. Recent Developments/Updates
7.15.6 Pacific Biosciences of California Inc. Competitive Strengths & Weaknesses
7.16 Life Technologies Corporation
7.16.1 Life Technologies Corporation Details
7.16.2 Life Technologies Corporation Major Business
7.16.3 Life Technologies Corporation Tumor NGS Detection Product and Services
7.16.4 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Life Technologies Corporation Recent Developments/Updates
7.16.6 Life Technologies Corporation Competitive Strengths & Weaknesses
7.17 GTH.O
7.17.1 GTH.O Details
7.17.2 GTH.O Major Business
7.17.3 GTH.O Tumor NGS Detection Product and Services
7.17.4 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 GTH.O Recent Developments/Updates
7.17.6 GTH.O Competitive Strengths & Weaknesses
7.18 Paradigm Diagnostics
7.18.1 Paradigm Diagnostics Details
7.18.2 Paradigm Diagnostics Major Business
7.18.3 Paradigm Diagnostics Tumor NGS Detection Product and Services
7.18.4 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Paradigm Diagnostics Recent Developments/Updates
7.18.6 Paradigm Diagnostics Competitive Strengths & Weaknesses
7.19 Oxford Nanopore Technologies Ltd.
7.19.1 Oxford Nanopore Technologies Ltd. Details
7.19.2 Oxford Nanopore Technologies Ltd. Major Business
7.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product and Services
7.19.4 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Oxford Nanopore Technologies Ltd. Recent Developments/Updates
7.19.6 Oxford Nanopore Technologies Ltd. Competitive Strengths & Weaknesses
7.20 Eurofins Scientific S.E.
7.20.1 Eurofins Scientific S.E. Details
7.20.2 Eurofins Scientific S.E. Major Business
7.20.3 Eurofins Scientific S.E. Tumor NGS Detection Product and Services
7.20.4 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Eurofins Scientific S.E. Recent Developments/Updates
7.20.6 Eurofins Scientific S.E. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor NGS Detection Industry Chain
8.2 Tumor NGS Detection Upstream Analysis
8.3 Tumor NGS Detection Midstream Analysis
8.4 Tumor NGS Detection Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Tumor NGS Detection Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Tumor NGS Detection Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Tumor NGS Detection Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Tumor NGS Detection Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Tumor NGS Detection Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor NGS Detection Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Tumor NGS Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Tumor NGS Detection Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Tumor NGS Detection Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Tumor NGS Detection Players in 2022
Table 12. World Tumor NGS Detection Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Tumor NGS Detection Company Evaluation Quadrant
Table 14. Head Office of Key Tumor NGS Detection Player
Table 15. Tumor NGS Detection Market: Company Product Type Footprint
Table 16. Tumor NGS Detection Market: Company Product Application Footprint
Table 17. Tumor NGS Detection Mergers & Acquisitions Activity
Table 18. United States VS China Tumor NGS Detection Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Tumor NGS Detection Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Tumor NGS Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor NGS Detection Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Tumor NGS Detection Revenue Market Share (2018-2023)
Table 23. China Based Tumor NGS Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor NGS Detection Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Tumor NGS Detection Revenue Market Share (2018-2023)
Table 26. Rest of World Based Tumor NGS Detection Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tumor NGS Detection Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Tumor NGS Detection Revenue Market Share (2018-2023)
Table 29. World Tumor NGS Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Tumor NGS Detection Market Size by Type (2018-2023) & (USD Million)
Table 31. World Tumor NGS Detection Market Size by Type (2024-2029) & (USD Million)
Table 32. World Tumor NGS Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Tumor NGS Detection Market Size by Application (2018-2023) & (USD Million)
Table 34. World Tumor NGS Detection Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Basic Information, Area Served and Competitors
Table 36. Agilent Major Business
Table 37. Agilent Tumor NGS Detection Product and Services
Table 38. Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Recent Developments/Updates
Table 40. Agilent Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Tumor NGS Detection Product and Services
Table 44. Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. BGI Group Basic Information, Area Served and Competitors
Table 48. BGI Group Major Business
Table 49. BGI Group Tumor NGS Detection Product and Services
Table 50. BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BGI Group Recent Developments/Updates
Table 52. BGI Group Competitive Strengths & Weaknesses
Table 53. Roche Foundation Medicine Basic Information, Area Served and Competitors
Table 54. Roche Foundation Medicine Major Business
Table 55. Roche Foundation Medicine Tumor NGS Detection Product and Services
Table 56. Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Foundation Medicine Recent Developments/Updates
Table 58. Roche Foundation Medicine Competitive Strengths & Weaknesses
Table 59. Sinopharm Group Basic Information, Area Served and Competitors
Table 60. Sinopharm Group Major Business
Table 61. Sinopharm Group Tumor NGS Detection Product and Services
Table 62. Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sinopharm Group Recent Developments/Updates
Table 64. Sinopharm Group Competitive Strengths & Weaknesses
Table 65. Fosunpharma Basic Information, Area Served and Competitors
Table 66. Fosunpharma Major Business
Table 67. Fosunpharma Tumor NGS Detection Product and Services
Table 68. Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Fosunpharma Recent Developments/Updates
Table 70. Fosunpharma Competitive Strengths & Weaknesses
Table 71. Novogene Basic Information, Area Served and Competitors
Table 72. Novogene Major Business
Table 73. Novogene Tumor NGS Detection Product and Services
Table 74. Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novogene Recent Developments/Updates
Table 76. Novogene Competitive Strengths & Weaknesses
Table 77. Geneseeq Basic Information, Area Served and Competitors
Table 78. Geneseeq Major Business
Table 79. Geneseeq Tumor NGS Detection Product and Services
Table 80. Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Geneseeq Recent Developments/Updates
Table 82. Geneseeq Competitive Strengths & Weaknesses
Table 83. AmoyDx Basic Information, Area Served and Competitors
Table 84. AmoyDx Major Business
Table 85. AmoyDx Tumor NGS Detection Product and Services
Table 86. AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. AmoyDx Recent Developments/Updates
Table 88. AmoyDx Competitive Strengths & Weaknesses
Table 89. Burning Rock Medicine Basic Information, Area Served and Competitors
Table 90. Burning Rock Medicine Major Business
Table 91. Burning Rock Medicine Tumor NGS Detection Product and Services
Table 92. Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Burning Rock Medicine Recent Developments/Updates
Table 94. Burning Rock Medicine Competitive Strengths & Weaknesses
Table 95. Perkin Elmer Basic Information, Area Served and Competitors
Table 96. Perkin Elmer Major Business
Table 97. Perkin Elmer Tumor NGS Detection Product and Services
Table 98. Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Perkin Elmer Recent Developments/Updates
Table 100. Perkin Elmer Competitive Strengths & Weaknesses
Table 101. Qiagen NV Basic Information, Area Served and Competitors
Table 102. Qiagen NV Major Business
Table 103. Qiagen NV Tumor NGS Detection Product and Services
Table 104. Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Qiagen NV Recent Developments/Updates
Table 106. Qiagen NV Competitive Strengths & Weaknesses
Table 107. Partek Basic Information, Area Served and Competitors
Table 108. Partek Major Business
Table 109. Partek Tumor NGS Detection Product and Services
Table 110. Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Partek Recent Developments/Updates
Table 112. Partek Competitive Strengths & Weaknesses
Table 113. Illumina Inc. Basic Information, Area Served and Competitors
Table 114. Illumina Inc. Major Business
Table 115. Illumina Inc. Tumor NGS Detection Product and Services
Table 116. Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Illumina Inc. Recent Developments/Updates
Table 118. Illumina Inc. Competitive Strengths & Weaknesses
Table 119. Pacific Biosciences of California Inc. Basic Information, Area Served and Competitors
Table 120. Pacific Biosciences of California Inc. Major Business
Table 121. Pacific Biosciences of California Inc. Tumor NGS Detection Product and Services
Table 122. Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pacific Biosciences of California Inc. Recent Developments/Updates
Table 124. Pacific Biosciences of California Inc. Competitive Strengths & Weaknesses
Table 125. Life Technologies Corporation Basic Information, Area Served and Competitors
Table 126. Life Technologies Corporation Major Business
Table 127. Life Technologies Corporation Tumor NGS Detection Product and Services
Table 128. Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Life Technologies Corporation Recent Developments/Updates
Table 130. Life Technologies Corporation Competitive Strengths & Weaknesses
Table 131. GTH.O Basic Information, Area Served and Competitors
Table 132. GTH.O Major Business
Table 133. GTH.O Tumor NGS Detection Product and Services
Table 134. GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. GTH.O Recent Developments/Updates
Table 136. GTH.O Competitive Strengths & Weaknesses
Table 137. Paradigm Diagnostics Basic Information, Area Served and Competitors
Table 138. Paradigm Diagnostics Major Business
Table 139. Paradigm Diagnostics Tumor NGS Detection Product and Services
Table 140. Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Paradigm Diagnostics Recent Developments/Updates
Table 142. Paradigm Diagnostics Competitive Strengths & Weaknesses
Table 143. Oxford Nanopore Technologies Ltd. Basic Information, Area Served and Competitors
Table 144. Oxford Nanopore Technologies Ltd. Major Business
Table 145. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product and Services
Table 146. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Oxford Nanopore Technologies Ltd. Recent Developments/Updates
Table 148. Eurofins Scientific S.E. Basic Information, Area Served and Competitors
Table 149. Eurofins Scientific S.E. Major Business
Table 150. Eurofins Scientific S.E. Tumor NGS Detection Product and Services
Table 151. Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Tumor NGS Detection Upstream (Raw Materials)
Table 153. Tumor NGS Detection Typical Customers
Table 1. World Tumor NGS Detection Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Tumor NGS Detection Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Tumor NGS Detection Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Tumor NGS Detection Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Tumor NGS Detection Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor NGS Detection Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Tumor NGS Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Tumor NGS Detection Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Tumor NGS Detection Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Tumor NGS Detection Players in 2022
Table 12. World Tumor NGS Detection Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Tumor NGS Detection Company Evaluation Quadrant
Table 14. Head Office of Key Tumor NGS Detection Player
Table 15. Tumor NGS Detection Market: Company Product Type Footprint
Table 16. Tumor NGS Detection Market: Company Product Application Footprint
Table 17. Tumor NGS Detection Mergers & Acquisitions Activity
Table 18. United States VS China Tumor NGS Detection Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Tumor NGS Detection Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Tumor NGS Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor NGS Detection Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Tumor NGS Detection Revenue Market Share (2018-2023)
Table 23. China Based Tumor NGS Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor NGS Detection Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Tumor NGS Detection Revenue Market Share (2018-2023)
Table 26. Rest of World Based Tumor NGS Detection Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tumor NGS Detection Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Tumor NGS Detection Revenue Market Share (2018-2023)
Table 29. World Tumor NGS Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Tumor NGS Detection Market Size by Type (2018-2023) & (USD Million)
Table 31. World Tumor NGS Detection Market Size by Type (2024-2029) & (USD Million)
Table 32. World Tumor NGS Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Tumor NGS Detection Market Size by Application (2018-2023) & (USD Million)
Table 34. World Tumor NGS Detection Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Basic Information, Area Served and Competitors
Table 36. Agilent Major Business
Table 37. Agilent Tumor NGS Detection Product and Services
Table 38. Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Recent Developments/Updates
Table 40. Agilent Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Tumor NGS Detection Product and Services
Table 44. Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. BGI Group Basic Information, Area Served and Competitors
Table 48. BGI Group Major Business
Table 49. BGI Group Tumor NGS Detection Product and Services
Table 50. BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BGI Group Recent Developments/Updates
Table 52. BGI Group Competitive Strengths & Weaknesses
Table 53. Roche Foundation Medicine Basic Information, Area Served and Competitors
Table 54. Roche Foundation Medicine Major Business
Table 55. Roche Foundation Medicine Tumor NGS Detection Product and Services
Table 56. Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Foundation Medicine Recent Developments/Updates
Table 58. Roche Foundation Medicine Competitive Strengths & Weaknesses
Table 59. Sinopharm Group Basic Information, Area Served and Competitors
Table 60. Sinopharm Group Major Business
Table 61. Sinopharm Group Tumor NGS Detection Product and Services
Table 62. Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sinopharm Group Recent Developments/Updates
Table 64. Sinopharm Group Competitive Strengths & Weaknesses
Table 65. Fosunpharma Basic Information, Area Served and Competitors
Table 66. Fosunpharma Major Business
Table 67. Fosunpharma Tumor NGS Detection Product and Services
Table 68. Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Fosunpharma Recent Developments/Updates
Table 70. Fosunpharma Competitive Strengths & Weaknesses
Table 71. Novogene Basic Information, Area Served and Competitors
Table 72. Novogene Major Business
Table 73. Novogene Tumor NGS Detection Product and Services
Table 74. Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novogene Recent Developments/Updates
Table 76. Novogene Competitive Strengths & Weaknesses
Table 77. Geneseeq Basic Information, Area Served and Competitors
Table 78. Geneseeq Major Business
Table 79. Geneseeq Tumor NGS Detection Product and Services
Table 80. Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Geneseeq Recent Developments/Updates
Table 82. Geneseeq Competitive Strengths & Weaknesses
Table 83. AmoyDx Basic Information, Area Served and Competitors
Table 84. AmoyDx Major Business
Table 85. AmoyDx Tumor NGS Detection Product and Services
Table 86. AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. AmoyDx Recent Developments/Updates
Table 88. AmoyDx Competitive Strengths & Weaknesses
Table 89. Burning Rock Medicine Basic Information, Area Served and Competitors
Table 90. Burning Rock Medicine Major Business
Table 91. Burning Rock Medicine Tumor NGS Detection Product and Services
Table 92. Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Burning Rock Medicine Recent Developments/Updates
Table 94. Burning Rock Medicine Competitive Strengths & Weaknesses
Table 95. Perkin Elmer Basic Information, Area Served and Competitors
Table 96. Perkin Elmer Major Business
Table 97. Perkin Elmer Tumor NGS Detection Product and Services
Table 98. Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Perkin Elmer Recent Developments/Updates
Table 100. Perkin Elmer Competitive Strengths & Weaknesses
Table 101. Qiagen NV Basic Information, Area Served and Competitors
Table 102. Qiagen NV Major Business
Table 103. Qiagen NV Tumor NGS Detection Product and Services
Table 104. Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Qiagen NV Recent Developments/Updates
Table 106. Qiagen NV Competitive Strengths & Weaknesses
Table 107. Partek Basic Information, Area Served and Competitors
Table 108. Partek Major Business
Table 109. Partek Tumor NGS Detection Product and Services
Table 110. Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Partek Recent Developments/Updates
Table 112. Partek Competitive Strengths & Weaknesses
Table 113. Illumina Inc. Basic Information, Area Served and Competitors
Table 114. Illumina Inc. Major Business
Table 115. Illumina Inc. Tumor NGS Detection Product and Services
Table 116. Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Illumina Inc. Recent Developments/Updates
Table 118. Illumina Inc. Competitive Strengths & Weaknesses
Table 119. Pacific Biosciences of California Inc. Basic Information, Area Served and Competitors
Table 120. Pacific Biosciences of California Inc. Major Business
Table 121. Pacific Biosciences of California Inc. Tumor NGS Detection Product and Services
Table 122. Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pacific Biosciences of California Inc. Recent Developments/Updates
Table 124. Pacific Biosciences of California Inc. Competitive Strengths & Weaknesses
Table 125. Life Technologies Corporation Basic Information, Area Served and Competitors
Table 126. Life Technologies Corporation Major Business
Table 127. Life Technologies Corporation Tumor NGS Detection Product and Services
Table 128. Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Life Technologies Corporation Recent Developments/Updates
Table 130. Life Technologies Corporation Competitive Strengths & Weaknesses
Table 131. GTH.O Basic Information, Area Served and Competitors
Table 132. GTH.O Major Business
Table 133. GTH.O Tumor NGS Detection Product and Services
Table 134. GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. GTH.O Recent Developments/Updates
Table 136. GTH.O Competitive Strengths & Weaknesses
Table 137. Paradigm Diagnostics Basic Information, Area Served and Competitors
Table 138. Paradigm Diagnostics Major Business
Table 139. Paradigm Diagnostics Tumor NGS Detection Product and Services
Table 140. Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Paradigm Diagnostics Recent Developments/Updates
Table 142. Paradigm Diagnostics Competitive Strengths & Weaknesses
Table 143. Oxford Nanopore Technologies Ltd. Basic Information, Area Served and Competitors
Table 144. Oxford Nanopore Technologies Ltd. Major Business
Table 145. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product and Services
Table 146. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Oxford Nanopore Technologies Ltd. Recent Developments/Updates
Table 148. Eurofins Scientific S.E. Basic Information, Area Served and Competitors
Table 149. Eurofins Scientific S.E. Major Business
Table 150. Eurofins Scientific S.E. Tumor NGS Detection Product and Services
Table 151. Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Tumor NGS Detection Upstream (Raw Materials)
Table 153. Tumor NGS Detection Typical Customers
LIST OF FIGURES
Figure 1. Tumor NGS Detection Picture
Figure 2. World Tumor NGS Detection Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor NGS Detection Total Market Size (2018-2029) & (USD Million)
Figure 4. World Tumor NGS Detection Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Tumor NGS Detection Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 13. Tumor NGS Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. World Tumor NGS Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. China Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. India Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Tumor NGS Detection by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor NGS Detection Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor NGS Detection Markets in 2022
Figure 27. United States VS China: Tumor NGS Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor NGS Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Tumor NGS Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Tumor NGS Detection Market Size Market Share by Type in 2022
Figure 31. Medical Equipment
Figure 32. Consumables
Figure 33. World Tumor NGS Detection Market Size Market Share by Type (2018-2029)
Figure 34. World Tumor NGS Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Tumor NGS Detection Market Size Market Share by Application in 2022
Figure 36. Companion Diagnostics
Figure 37. Early Cancer Screening
Figure 38. Drug Discovery
Figure 39. Other
Figure 40. Tumor NGS Detection Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Tumor NGS Detection Picture
Figure 2. World Tumor NGS Detection Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor NGS Detection Total Market Size (2018-2029) & (USD Million)
Figure 4. World Tumor NGS Detection Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Tumor NGS Detection Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Tumor NGS Detection Revenue (2018-2029) & (USD Million)
Figure 13. Tumor NGS Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. World Tumor NGS Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. China Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. India Tumor NGS Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Tumor NGS Detection by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor NGS Detection Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor NGS Detection Markets in 2022
Figure 27. United States VS China: Tumor NGS Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor NGS Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Tumor NGS Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Tumor NGS Detection Market Size Market Share by Type in 2022
Figure 31. Medical Equipment
Figure 32. Consumables
Figure 33. World Tumor NGS Detection Market Size Market Share by Type (2018-2029)
Figure 34. World Tumor NGS Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Tumor NGS Detection Market Size Market Share by Application in 2022
Figure 36. Companion Diagnostics
Figure 37. Early Cancer Screening
Figure 38. Drug Discovery
Figure 39. Other
Figure 40. Tumor NGS Detection Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
